ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025
Provided By GlobeNewswire
Last update: Jul 9, 2025
PORTLAND, Maine, July 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales results for the second quarter of 2025.
Read more at globenewswire.com
